Target Name: ZNF3
NCBI ID: G7551
Review Report on ZNF3 Target / Biomarker Content of Review Report on ZNF3 Target / Biomarker
ZNF3
Other Name(s): PP838 | ZNF3 variant 1 | A8-51 | Zinc finger protein KOX25 | ZNF3 variant 2 | Zfp113 | C2-H2 type zinc finger protein | zinc finger protein KOX25 | OTTHUMP00000206970 | HZF3.1 | OTTHUMP00000206974 | Zinc finger protein 3 | ZNF3 variant 3 | Zinc finger protein 3, transcript variant 3 | Zinc finger protein 3, transcript variant 6 | zinc finger protein HZF3.1 | Zinc finger protein HF.12 | KOX25 | OTTHUMP00000206973 | Zinc finger protein 3 (isoform 3) | zinc finger protein 3 | zinc finger protein HF.12 | Zinc finger protein 3, transcript variant 2 | Zinc finger protein 3 (isoform 1) | HF.12 | FLJ20216 | Zinc finger protein 3, transcript variant 1 | ZNF3 variant 6 | Zinc finger protein 3 (isoform 2) | Zinc finger protein HZF3.1 | OTTHUMP00000207034 | ZNF3_HUMAN | OTTHUMP00000206972

ZNF3: A Non-Coding RNA Molecule Implicated in Diseases

ZNF3 (Zinc Finger Nucleotide) is a non-coding RNA molecule that plays a crucial role in various cellular processes. It is a key regulator of gene expression and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders. ZNF3 is also a potential drug target and biomarker for several diseases.

ZNF3 is a protein that contains a zinc finger domain and a non-coding RNA sequence. The zinc finger domain is a common structural element that is found in proteins that regulate gene expression. The non-coding RNA sequence is responsible for binding to specific DNA sequences and regulating gene expression.

ZNF3 is a transcriptional regulator that regulates gene expression by binding to specific DNA sequences. It has been shown to play a role in the regulation of stem cell proliferation and differentiation. ZNF3 has also been shown to be involved in the regulation of tissue repair and regeneration.

In addition to its role in stem cell biology, ZNF3 is also implicated in the development and progression of a number of diseases. For example, ZNF3 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. It has also been implicated in the development of cancer, with studies showing that high levels of ZNF3 are associated with an increased risk of cancer.

As a potential drug target, ZNF3 is being targeted by several research groups to study its role in disease. For example, researchers at the University of California, San Francisco have shown that inhibiting the activity of ZNF3 can protect against neurodegenerative diseases, such as Alzheimer's disease. Other researchers have also shown that inhibiting the activity of ZNF3 can inhibit the growth of cancer cells.

In addition to its potential as a drug target, ZNF3 is also being studied as a biomarker for several diseases. For example, researchers at the University of California, Davis have shown that ZNF3 levels can be used as a biomarker for cancer. They have also shown that ZNF3 levels can be used as a biomarker for neurodegenerative diseases, such as Alzheimer's disease.

Overall, ZNF3 is a non-coding RNA molecule that plays a crucial role in various cellular processes. It is a key regulator of gene expression and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders. ZNF3 is also a potential drug target and biomarker for several diseases. Further research is needed to fully understand its role in these processes and to develop effective treatments.

Protein Name: Zinc Finger Protein 3

Functions: Involved in cell differentiation and/or proliferation

The "ZNF3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A | ZNF33B | ZNF33BP1 | ZNF34 | ZNF341 | ZNF341-AS1 | ZNF343 | ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A | ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418 | ZNF419 | ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429 | ZNF43 | ZNF430 | ZNF431 | ZNF432 | ZNF433 | ZNF433-AS1 | ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442